K993571

Substantially Equivalent

BAYER DIAGNOSTICS ACS:180 VB12, BAYER DIAGNOSTICS ADVIA CENTAUE VB12

Applicant: Bayer Corp.
Product code: CDD
Advisory panel: Clinical Chemistry
Date received: 1999-10-21
Decision date: 1999-12-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Medfield, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.